Dr. Narine Petrosyan

Dr. Narine Petrosyan is a consultant medical oncologist at the National Oncology Center of Armenia — the country's principal cancer institution in Yerevan. With 18 years of oncology practice, Dr. Petrosyan is one of Armenia's most experienced medical oncologists, managing the spectrum of common solid tumors including breast cancer, colorectal cancer, and lung cancer, and working to bring ESMO-standard systemic therapy to Armenian cancer patients.

Armenia has made progress in developing oncology services, though resource constraints limit access to some targeted therapies and clinical trial opportunities available in Western Europe. Dr. Petrosyan advocates for her patients' access to novel therapies and works with international oncology networks and diaspora physician organizations to stay current with rapidly evolving cancer medicine.

Her breast oncology practice applies hormone receptor, HER2, and Ki-67 molecular markers to treatment decisions, prescribing anthracycline and taxane-based chemotherapy, trastuzumab, CDK4/6 inhibitors where available, and aromatase inhibitors for hormone receptor-positive disease. She coordinates with surgical and radiation oncology colleagues through the National Oncology Center's multidisciplinary tumor board.

Dr. Petrosyan trained in Germany and holds the ESMO certification. She communicates in Armenian, Russian, and English — essential for serving both Armenian nationals and diaspora patients who return to Yerevan for cancer care.

Dr. Petrosyan obtained her MD from Yerevan State Medical University and completed Oncology residency at the National Oncology Center of Armenia. She undertook a Medical Oncology Fellowship at the University Hospital Heidelberg in Germany — one of Europe's leading comprehensive cancer centers. She holds a PhD in Oncology from Yerevan State Medical University and the ESMO certification. She maintains active ESMO membership and participates in ESMO East program activities.

Dr. Petrosyan's oncology practice covers solid tumors and lymphoma. In breast cancer, she designs neoadjuvant and adjuvant chemotherapy regimens (AC-T, FEC-D, TCH), prescribes trastuzumab for HER2-positive disease, CDK4/6 inhibitors for hormone receptor-positive metastatic breast cancer, and PARP inhibitors for BRCA-mutated disease where available. For colorectal cancer, she manages FOLFOX and FOLFIRI regimens with bevacizumab and EGFR antibodies for appropriate RAS wild-type patients. She manages lung cancer with platinum-based doublets and targeted agents where molecular testing supports it. She performs bone marrow biopsies for lymphoma staging and manages CHOP/R-CHOP regimens for lymphoma.

Dr. Petrosyan has published in the Yerevan State Medical University scientific bulletin and the Armenian Journal of Oncology on breast and colorectal cancer outcomes in Armenia, cancer epidemiology, and access to targeted therapies. She participates in the Armenian Society of Clinical Oncology and ESMO East network. She presents at the National Oncology Center annual conference and ESMO regional meetings.

The National Oncology Center of Armenia serves the domestic Armenian population and diaspora Armenians who return to Yerevan for cancer treatment. Dr. Petrosyan consults in Armenian, Russian, and English. Video consultations are available for oncology second opinions for diaspora Armenians in the United States, France, Russia, and elsewhere who seek the perspective of an Armenian oncologist familiar with the local healthcare context.

Dr. Petrosyan has been recognized by the Armenian Society of Clinical Oncology for her contributions to breast cancer care in Armenia and her advocacy for improved access to targeted oncology therapies. She serves on the National Oncology Center clinical guidelines committee and the Armenian Ministry of Health oncology advisory panel.